A comprehensive review of vaccine literature from 2020 onwards examines novel vaccine platforms for respiratory viruses, highlighting the successful deployment of mRNA technology during the COVID-19 pandemic.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Novel vaccine platforms for respiratory viruses: a review of licensed vaccines and candidates in late-stage development.
2020 To Present Research period
MRNA Vaccine Platforms Technology focus
Respiratory Virus Vaccines Primary application